NEWS

Evonik

Chemetall and Londian Wason Partner on New Chromium- and Fluoride-Free Copper Foil Tech

Chemetall and Londian Wason Form Strategic Partnership to Advance Sustainable Copper Foil Technologies for the Next Generation of Energy Solutions Chemetall, a leading global provider of innovative surface treatment solutions and the Surface Treatment business unit of BASF Coatings, has…

Read MoreChemetall and Londian Wason Partner on New Chromium- and Fluoride-Free Copper Foil Tech

AskBio Publishes 12-Month Phase 1 AB-1002 Gene Therapy Data for Congestive Heart Failure in Nature Medicine

Long-Term Data Demonstrate Safety and Preliminary Efficacy of Investigational One-Time Gene Therapy in Patients with Non-Ischemic Heart Failure  AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced the publication…

Read MoreAskBio Publishes 12-Month Phase 1 AB-1002 Gene Therapy Data for Congestive Heart Failure in Nature Medicine

Pimicotinib Treatment Shows Lasting Tumor Response and Improved Pain and Function in TGCT Patients

Merck Announces Promising Long-Term Results of Pimicotinib in Phase 3 MANEUVER Trial for TGCT Treatment Merck, a leading global science and technology company, has today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial. This pivotal…

Read MorePimicotinib Treatment Shows Lasting Tumor Response and Improved Pain and Function in TGCT Patients
Drug Farm, Cincinnati Children’s Partner on ALPK1

Drug Farm, Cincinnati Children’s Partner on ALPK1 Inhibitor for Heart Disease and Blood Cancers

Drug Farm, a private biotechnology company pioneering the use of genetics and artificial intelligence to discover and develop innovative immune-modulating therapies, announced today that it has entered into a Material Transfer Agreement (MTA) with Cincinnati Children’s Hospital Medical Center (CCHMC).…

Read MoreDrug Farm, Cincinnati Children’s Partner on ALPK1 Inhibitor for Heart Disease and Blood Cancers